NSEUpdates2 Nov 2026 · 2 Nov 2026, 11:12 pm
Updates
India Glycols Limited · INDIAGLYCO
✦ AI SummaryM&A
India Glycols Limited has informed the Exchange regarding 'Material Update' related to IGL Spirits Limited, which has received Listing and Trading Approvals from BSE and NSE for the equity shares issued and allotted pursuant to the Scheme of Arrangement.
Analysis Scores
Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
India Glycols Limited has informed the Exchange regarding 'Material Update'.
Attachments (1)
📄pdf
Download →
INDIAGLYCO_02112026231155_Intimation_ISL_.pdf
View document text
IGL/SE/2026-27/72
2nd November, 2026
The Manager (Listing) The Manager (Listing)
BSE Limited National Stock Exchange of India Limited
1st Floor, New Trading Ring, Exchange Plaza, C-1, Block G,
Rotunda Building, P.J. Towers, Bandra Kurla Complex,
Dalal Street, Mumbai – 400 001 Bandra (East), Mumbai- 400 051
Scrip Code: 500201 Symbol: INDIAGLYCO
Dear Sirs,
Sub.: Material Update in Connection with IGL Spirits Limited with reference to Observation
letter no. NSE/LIST/48932 dated 17th November, 2025 and no.
DCS/AMAL/TS/R37/3905/2025-26 dated 19th November, 2025 ("Observation Letters"),
issued by the National Stock Exchange of India Limited and BSE Limited (collectively the
"Stock Exchanges"), respectively, received in relation to the Scheme of Arrangement.
With reference to captioned above, we would like to inform you that IGL Spirts Limited
(“IGSL”), through its letter dated 2nd November, 2026, has communicated to the
Company certain material events/ updates in relation to IGSL, which is enclosed herein
as Annexure A.
This disclosure is being made in respect of IGSL, pursuant to the requirement in the
Observation Letters and SEBI Master Circular No. HO/491l 411 4(7)2025-CFD-POD21l
13762/2026 dated 30th January, 2026 (as amended).
You are requested to take the same on record.
Thanking you,
Yours faithfully,
For India Glycols Limited
Ankur Jain
Head (Legal) & Company Secretary
Encl: A/a
Date: November 02, 2026
India Glycols Limited
Plot No. 2-B & 2-C,
Sector – 126, Noida,
Uttar Pradesh – 201304
Subject: Intimation regarding receipt of Listing and Trading Approvals in connection
with the Scheme of Arrangement amongst India Glycols Limited (“Demerged
Company”), Ennature Bio Pharma Limited (“Resulting Company 1”) and IGL Spirits
Limited (“Resulting Company 2”) and their respective shareholders and creditors under
Sections 230 to 232 and other applicable provisions of the Companies Act, 2013
(“Scheme”).
Dear Sir/Madam,
This is to inform you that IGL Spirits Limited (“ISL”) has received the Listing and Trading
Approvals from BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”)
on November 02, 2026, in respect of the equity shares issued and allotted pursuant to the
Scheme.
The relevant details are as under:
Name of the Stock Exchanges: BSE and NSE
Type of Approval: Listing and Trading Approval
Security Type: Equity Shares
Number of Shares Listed: 6,70,26,765 Equity shares of Rs. 5/- each
Date of Approval: November 02, 2026
Date of Commencement of Trading: November 04, 2026
Copy of the Listing and Trading Approval letters received are available on the websites of BSE
and NSE at https://www.bseindia.com/markets/marketinfo/noticescirculars?id=0 and
https://www.nseindia.com/resources/exchange-communication-circulars respectively.
You are requested to kindly take the above information on record.
Thanking You.
Yours faithfully,
For IGL Spirits Limited
Ishan Khanna
Company Secretary